This article first appeared with Targeted Oncology™. An orphan drug designation (ODD) was granted by the FDA to elraglusib for the treatment of patients with soft tissue sarcoma (STS). 1 Currently, a ...
Highlighting the urgent need for awareness and support for sarcoma, a rarely discussed but serious cancer affecting many.
Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the limb significantly improved disease-free survival, according to the results ...
The Courage Ride typically attracts 400 to 500 cyclists. The event is in its 20th year of raising funds for sarcoma research. The 20th annual Courage Ride brings together sarcoma patients, survivors, ...
US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant, PIK3CA-Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor ...
While cancers such as breast, lung, and prostate frequently dominate public health discussions, there is a far less recognised but equally aggressive form - sarcoma. It affects thousands across the UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback